Showing results (41-50 of 195) with videos related to
Sort By:
Pageof 20
Expert Review of Clinical Immunology|May 27, 2023
Topical roflumilast for the treatment of psoriasisAnastasia Drakos, Ron Vender, Tiago TorresDrugs|September 25, 2025
JAK Inhibitors for the Treatment of Vitiligo: Current Evidence and Emerging Therapeutic PotentialCésar Ferreira, Brett King, Tiago TorresBiodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|June 8, 2019
Bimekizumab: The First Dual Inhibitor of Interleukin (IL)-17A and IL-17F for the Treatment of Psoriatic Disease and Ankylosing SpondylitisJoel Reis, Ron Vender, Tiago TorresThe Journal of International Medical Research|March 12, 2024
Risankizumab, a therapeutic alternative for psoriasis in people living with HIVTomás Estevinho, Egídio Freitas, Tiago TorresDrugs in Context|June 2, 2020
Psoriasis, biologic therapy, and the pandemic of the 21st centuryMiguel Nogueira, Ron Vender, Tiago TorresDrugs|February 6, 2020
JAK Inhibitors for Treatment of Psoriasis: Focus on Selective TYK2 InhibitorsMiguel Nogueira, Luis Puig, Tiago TorresDrugs|May 21, 2022
New Topical Therapies in Development for Atopic DermatitisEgídio Freitas, Melinda Gooderham, Tiago TorresDrugs in Context|April 23, 2021
Selective IL-13 inhibitors for the treatment of atopic dermatitisFrancisca Gonçalves, Egídio Freitas, Tiago TorresPharmaceutics|July 27, 2024
New and Emerging Treatments for Generalized Pustular Psoriasis: Focus on IL-36 Receptor InhibitorsJoão Vilaça, Orhan Yilmaz, Tiago TorresPharmaceutics|January 23, 2024
Emerging Oral Therapies for the Treatment of Psoriasis: A Review of Pipeline AgentsAnastasia Drakos, Tiago Torres, Ronald VenderPageof 20